No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition.
暂无分享，去创建一个
F. Clavel-Chapelon | F. Berrino | E. Riboli | A. Tjønneland | K. Overvad | H. Boshuizen | G. Nagel | G. Berglund | A. Berenguer | G. Capellá | T. Key | P. Peeters | G. Pera | A. Trichopoulou | G. Hallmans | M. Numans | K. Khaw | H. Boeing | T. Norat | D. Palli | S. Bingham | S. Panico | R. Tumino | C. González | M. Jenab | C. Sacerdote | C. Navarro | P. Amiano | R. Stenling | A. Olsen | M. Boutron‐Ruault | E. Lund | A. Agudo | P. Ferrari | J. Quirós | N. Allen | F. Carneiro | J. Linseisen | A. Barricarte | N. Sala | H. Bläker | G. Del Giudice | C. Saieva | C. Martínez | H. Bueno-de-Mesquita | H. Simán | Nadia García | P. Ferrari
[1] Zuo-Feng Zhang,et al. Cytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer. , 2005, World journal of gastroenterology.
[2] G. La Torre,et al. Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. , 2005, Cancer letters.
[3] Y. Oda,et al. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer , 2004, Journal of Gastroenterology.
[4] W. Han,et al. Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development. , 2003, Pharmacogenetics.
[5] N E Day,et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.
[6] M. Voso,et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. , 2002, Blood.
[7] G. Capellá,et al. Genetic susceptibility and gastric cancer risk , 2002, International journal of cancer.
[8] Á. Rodríguez-Lescure,et al. N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma , 2002, European Journal of Clinical Pharmacology.
[9] Chien-Jen Chen,et al. Genetic polymorphisms of cytochrome P450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan , 2002, International Journal of Colorectal Disease.
[10] P. Simpson,et al. Statistical methods in cancer research , 2001, Journal of surgical oncology.
[11] D. Bell,et al. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma , 2000, International journal of cancer.
[12] S. Tsugane,et al. Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[13] Y. Oda,et al. Genotypes of glutathione S-transferase M1 and N-acetyltransferase 2 in Japanese patients with gastric cancer , 1999, Gastric Cancer.
[14] P. Vineis. Metabolic Polymorphisms and Susceptibility to Cancer , 1999 .
[15] N. Breslow,et al. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. , 1981 .
[16] M. Doll,et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[17] N. Breslow,et al. The analysis of case-control studies , 1980 .